PictorLabs is a digital pathology company advancing AI-powered virtual staining technology to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes. Led by a team with deep expertise in bioengineering, artificial intelligence, and health-tech product development, the Company is reimagining existing histopathology workflows, accelerating clinical and diagnostic results, and improving process sustainability. From a single unstained tissue sample, PictorLabs' proprietary platform can produce an unlimited number of virtual stains that are indistinguishable from analogous chemical stains. PictorLabs is developing products that replicate standard of care stains and is creating specialized virtual biomarker stains for indications in which there is a large demand for novel and accelerated diagnostic tests.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/01/22 | $15,200,000 | Seed |
Koc Holding M Ventures SCC Soft Computer | undisclosed |
| 09/18/24 | $30,000,000 | Series B |
Insight Partners M Ventures | undisclosed |
